Chinese mainland reports 141 new local confirmed COVID-19 cases
Residents queue for nucleic acid tests at a residential area in Xiqing District, north China's Tianjin, May 21, 2022. Mass nucleic acid tests have been launched at 8 p.m. Friday in Tianjin's Nankai, Hongqiao, Hexi, Hedong and Heping districts in face of the recent COVID-19 outbreak. Other districts in the municipality carried out mass nucleic acid tests on Saturday. (Xinhua/Li Ran)
BEIJING, May 24 (Xinhua) -- The Chinese mainland on Monday reported 141 locally-transmitted confirmed COVID-19 cases, of which 58 were in Shanghai and 41 in Beijing, the National Health Commission said Tuesday.
Apart from the two metropolitan cities, six other provincial-level regions on the mainland also saw new local COVID-19 cases, including 19 in Sichuan and 16 in Tianjin.
Shanghai also reported 422 locally-transmitted asymptomatic infections of the novel coronavirus Monday, out of a total of 498 local asymptomatic carriers newly identified on the mainland.
Following the recovery of 474 COVID-19 patients who were discharged from hospitals on Monday, there were 3,956 confirmed COVID-19 cases receiving treatment in hospitals across the Chinese mainland.
One new death from COVID-19 was reported in Shanghai, according to the commission.
Photos
- China’s central bank to issue commemorative coins on cultural theme of auspiciousness, including two heart-shaped coins
- Population of endangered black-headed gulls exceeds 10,000 mark in NE China’s coastal city of Panjin
- China's self-developed floating airship breaks record
- Chinese germplasm bank conserves biodiversity in warm temperate zone
Related Stories
- Shanghai reports 58 confirmed, 422 asymptomatic local COVID-19 cases
- Beijing reports 63 new local COVID-19 infections
- China steps up COVID-19 prevention measures for safe flights
- 848 COVID-19 patients discharged from hospitals, released from quarantine in Beijing
- China strengthens COVID-19 control over cold-chain food imports
Copyright © 2022 People's Daily Online. All Rights Reserved.